Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania.

Stefana BucurElena-Daniela Serban Bogdan Vasile IleanuRaluca Simona CostacheAlin Codrut NicolescuTraian ConstantinDaniel Octavian Costache Maria-Magdalena Constantin

Published in: Psoriasis (Auckland, N.Z.) (2024)

This study contributes to the understanding of the drug survival profile and the factors that may influence it in ixekizumab and secukinumab treatment in a real-world setting.

Keyphrases

ankylosing spondylitis
randomized controlled trial
drug induced
free survival
systematic review
coronary artery disease
adverse drug
early onset
big data
emergency department
rheumatoid arthritis
machine learning
combination therapy